Rohollah Valizadeh
1,2 
, Nahid Dadashzadeh
3, Roya Zakeri
4, Steven James Kellner
5 , Mohsen Mohammad Rahimi
6* 1 Student Research Committee, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
2 Nickan Research Institute, Isfahan, Iran
3 Legal Medicine Research Center, Iranian Legal Medicine Organization, Tehran, Iran
4 Pediatrics Specialist, Tabriz University of Medical Sciences, Tabriz, Iran
5 Head International Research and Development, Mesencell Biotech International Ltd, 20-22 Wenlock Road, London, N1 7GU, UK
6 Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Implication for health policy/practice/research/medical education:
To treat COVID-19, the first choice should be antiviral drugs and sometimes a small dose of anti-inflammatory drugs to reduce inflammation. In this regard, chloroquine has both features including antiviral activity and anti-inflammatory effect.
Please cite this paper as: Valizadeh R, Dadashzadeh N, Zakeri R, James Kelllner S, Rahimi MM. Drug therapy in hospitalized patients with very severe symptoms following COVID-19. J Nephropharmacol. 2020;9(2):e21. DOI: 10.34172/npj.2020.21